|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/14 | |
| A61K 31/4245 | |||
| A61K 31/4196 | |||
| A61K 31/497 | |||
| A61P 35/00 |
| (11) | Number of the document | 2948447 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14701828.7 |
| Date of filing the European patent application | 2014-01-22 | |
| (97) | Date of publication of the European application | 2015-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/050163 |
| Date | 2014-01-22 |
| (87) | Number | WO 2014/114928 |
| Date | 2014-07-31 |
| (30) | Number | Date | Country code |
| 13305078 | 2013-01-23 | EP |
| (72) |
BARLAAM, Bernard Christophe, GB
BERRY, David, GB
DELOUVRIE, Benedicte, GB
HARRIS, Craig Steven, GB
LAMBERT-VAN DER BREMPT, Christine Marie Paul, GB
OUVRY, Gilles, GB
REID, Gary Patrick, GB
TOMKINSON, Gary Peter, GB
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (54) | CHEMICAL COMPOUNDS |
| CHEMICAL COMPOUNDS |